No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
105 |
4. Check minimum number of eventsNone |
105 |
5. Include endpointsNone |
105 |
6. Filter based on genotype QC (FinnGen only) |
105 |
Control definitions (FinnGen only)
- Control exclude
- ASTHMA_ALLERG
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L23
- Name in latin
- Eczema allergicum ex contactu nutrimentorum
Similar endpoints
↥List of similar endpoints to
Food allergy
based on the number of shared cases.
Similar with more cases:
- Allergic contact dermatitis
- Dermatitis and eczema
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1444 | 806 | 635 |
| Only index persons | 1161 | 681 | 480 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 15.11 | 23.09 | 4.90 |
| Only index persons | 19.59 | 26.47 | 9.83 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 105 | 77 | 28 |
| Unadjusted period prevalence (%) | 0.02 | 0.03 | 0.01 |
| Median age at first event (years) | 33.18 | 34.94 | 28.32 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 95
- Matched controls
- 948
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L23.6
ICD-10 Finland
Allergic contact dermatitis due to food in contact with skin
+∞
134.9
95
*
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
14.9
24.6
45
54
XQ800
NOMESCO Finland
Prick test
16.8
20.1
33
29
L20.0
ICD-10 Finland
Besnier prurigo
8.4
14.2
34
59
C01CA24
ATC
epinephrine; parenteral
8.3
10.6
24
37
E0000UV
ATC
NA
3.8
9.0
59
285
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
10.6
9.0
17
19
XQ802
NOMESCO Finland
Epicutan test
10.1
8.8
17
20
J45.0
ICD-10 Finland
Predominantly allergic asthma
8.9
7.8
16
21
E000002
ATC
NA
4.8
7.6
27
73
J30.3
ICD-10 Finland
Other allergic rhinitis
11.4
7.3
13
13
E000001
ATC
NA
3.7
7.3
37
139
D07AC13
ATC
mometasone; topical
3.6
7.2
40
160
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
7.2
7.2
17
28
T78.4
ICD-10 Finland
Allergy, unspecified
6.4
6.7
17
31
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
19.6
6.4
9
5
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
19.6
6.4
9
5
L27.2
ICD-10 Finland
Dermatitis due to ingested food
19.6
6.4
9
5
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004119) Hemoglobin [Mass/volume] in Venous blood
12
27
4.89
5.18
3.7
3.4
g/l
135.8
133.6
0.15
12
27
(3027273) Bicarbonate [Moles/volume] in Venous blood
10
25
4.32
3.79
4.3
2.4
mmol/l
24.6
23.8
—
10
25
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
10
26
4.15
3.61
5.4
3.0
%
48.9
52.4
—
10
26
(44813793)
5
5
10.40
3.01
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
13
5.68
2.92
6.6
2.8
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
7
13
5.68
2.92
4.0
2.5
mmol/l
6.2
6.8
—
7
13
(3008037) Lactate [Moles/volume] in Venous blood
7
13
5.68
2.92
4.0
2.5
mmol/l
1.3
1.2
—
7
13
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
91
751
2.59
2.88
2.9
3.3
mmol/l
1.2
1.3
0.64
85
704
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
93
788
2.58
2.55
3.0
3.5
mmol/l
1.5
1.5
0.11
88
744
(3005322) IgE [Units/volume] in Serum or Plasma
14
59
2.58
2.41
2.4
1.3
u/ml
497.2
513.3
0.01
14
54
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
93
797
2.46
2.32
3.4
3.8
mmol/l
2.8
2.8
0.04
87
752
(3041354) Potassium [Moles/volume] in Venous blood
5
9
5.77
2.24
3.4
2.4
mmol/l
3.8
3.9
—
5
9
(3035285) Chloride [Moles/volume] in Venous blood
5
9
5.77
2.24
3.4
2.4
mmol/l
107.8
105.8
—
5
9
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
9
5.77
2.24
3.4
2.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
45
315
1.75
2.03
3.6
3.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
81
680
1.84
1.84
4.2
3.9
pmol/l
14.4
14.5
0.19
75
627
(3000494) Fungus identified in Specimen by Culture
16
83
2.09
1.76
1.8
1.7
—
—
—
0
0
(3015736) pH of Urine
43
309
1.66
1.71
3.0
3.1
—
—
—
0
0
(3012544) pH of Venous blood
13
64
2.18
1.62
3.6
3.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
53
409
1.60
1.55
6.1
4.5
estimate
0.0
0.0
0.00
12
95
(3035350) Ketones [Presence] in Urine by Test strip
53
409
1.60
1.55
3.1
3.3
estimate
0.0
0.0
0.00
12
95
(3041096) Erythrocytes [Presence] in Urine by Automated
35
244
1.65
1.54
4.1
3.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
15
3.44
1.54
2.4
5.5
e9/l
3.9
3.8
—
5
15
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
15
3.44
1.54
2.4
5.5
%
57.6
57.9
—
5
15
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
36
253
1.64
1.53
2.1
2.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
52
2.25
1.50
1.6
1.2
—
—
—
0
0
(3000492) Spirometry study
14
75
2.00
1.42
1.0
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
53
415
1.56
1.42
3.7
3.3
estimate
0.0
0.0
0.00
11
91
(40768443) Skin Pathology biopsy report
6
24
2.59
1.32
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
25
2.48
1.26
1.2
1.6
—
—
—
0
0
(4034850)
5
19
2.71
1.23
3.8
5.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
11
57
2.04
1.22
3.5
3.7
%
—
0.6
—
0
11
(1761868) Lipid panel - Serum or Plasma
42
322
1.51
1.19
2.0
2.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
51
2.06
1.15
4.4
2.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
95
876
1.89
1.09
11.8
11.5
mg/l
15.4
20.0
0.85
77
650
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
85
764
1.59
1.05
8.9
9.5
ml/min/173m2
91.2
93.5
0.44
72
599
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
22
2.33
1.04
1.2
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
14
84
1.77
1.04
2.0
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
11
61
1.90
1.03
3.5
3.9
%
—
0.5
—
0
13
(3002582) Erythrocytes [#/volume] in Urine
31
231
1.49
0.99
2.1
3.0
e6/l
17.9
318.4
0.56
24
180
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
17
110
1.65
0.98
1.9
2.5
e6/l
3.1
0.8
0.78
11
66
(3000330) Specific gravity of Urine by Test strip
7
37
1.95
0.96
6.6
1.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
28
206
1.49
0.95
2.2
2.7
e6/l
0.3
0.2
0.18
20
158
(3021440) Promyelocytes/100 leukocytes in Blood
10
56
1.87
0.91
3.7
4.1
%
—
0.1
—
0
12
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
29
2.13
0.91
2.0
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
23
165
1.50
0.87
2.5
4.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
54
458
1.37
0.82
5.0
5.7
e9/l
1.9
2.2
0.81
49
415
(3019060) Gas panel - Arterial blood
6
33
1.87
0.80
3.7
18.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
29
223
1.42
0.78
2.1
1.3
g/l
2.5
2.1
0.73
21
135
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
23
2.23
0.77
1.2
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
14
92
1.60
0.77
1.0
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
29
224
1.41
0.76
3.2
4.8
inr
1.1
1.0
0.29
11
79
(40760892) CBC W Ordered Manual Differential panel - Blood
28
216
1.40
0.74
3.7
4.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
36
290
1.37
0.74
1.7
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
25
2.05
0.73
1.0
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
9
58
1.60
0.72
4.0
3.9
%
—
0.0
—
0
11
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
58
1.60
0.72
1.1
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
26
1.97
0.71
1.2
1.3
—
13.0
—
0
7
(3001604) Monocytes [#/volume] in Blood
51
437
1.32
0.69
4.9
5.6
e9/l
0.5
0.5
0.00
45
395
(3002385) Erythrocyte distribution width [Ratio]
83
765
1.41
0.68
11.7
13.8
%
13.4
13.5
0.32
83
751
(3006315) Basophils [#/volume] in Blood
51
438
1.32
0.68
5.0
5.6
e9/l
0.0
0.0
0.30
45
396
(3013115) Eosinophils [#/volume] in Blood
53
459
1.31
0.66
4.9
6.5
e9/l
0.2
0.2
0.34
48
419
(3003338) MCHC [Mass/volume]
86
799
1.42
0.65
11.5
14.1
g/l
333.6
333.4
0.06
86
794
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
29
1.76
0.64
2.8
2.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
67
601
1.32
0.64
7.0
7.0
u/l
79.8
75.2
0.42
62
559
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
111
0.60
0.62
1.3
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
30
1.70
0.62
3.2
1.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
15
106
1.48
0.62
2.0
2.6
e6/l
4.0
4.5
—
10
63
(3018095) Leukocytes [#/volume] in Urine
34
279
1.32
0.61
2.9
3.4
e6/l
11.6
36.7
0.98
26
190
(21494755) Public health laboratory ask at order entry panel
16
115
1.46
0.61
1.2
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
22
169
1.38
0.59
1.1
1.3
iu/ml
35.0
24.7
—
7
54
(3021589) Normoblasts [#/volume] in Blood
46
395
1.29
0.59
7.6
7.3
e9/l
0.0
0.0
0.50
39
323
(40761511) CBC panel - Blood by Automated count
96
919
1.52
0.56
10.9
10.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
38
1.61
0.55
1.7
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
81
753
1.33
0.55
3.7
3.9
—
—
—
0
0
(4010399)
6
39
1.57
0.54
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
65
1.42
0.52
1.3
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
63
571
1.26
0.50
3.9
4.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
48
1.49
0.48
1.1
3.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
112
1.40
0.48
1.4
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
158
1.33
0.46
1.4
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
57
514
1.24
0.46
7.0
9.8
e9/l
3.6
4.0
1.01
52
466
(3013512) EKG study
22
177
1.31
0.45
4.8
3.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
25
205
1.29
0.45
1.7
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
27
224
1.28
0.44
1.8
2.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
13
96
1.40
0.44
1.2
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
33
282
1.25
0.43
1.9
1.7
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
20.3
—
1671.7
—
0
15
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
11.5
—
887.7
—
0
15
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
2.9
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
17
0.00
0.41
0.0
2.0
—
6.9
—
0
9
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
17
0.00
0.41
0.0
2.6
—
0.0
—
0
17
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
17
0.00
0.41
0.0
2.6
—
0.0
—
0
17
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
17
0.00
0.41
0.0
2.6
—
0.0
—
0
17
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
28
237
1.25
0.39
4.3
2.6
ng/l
9.9
17.5
2.07
16
120
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
95
915
1.40
0.39
8.5
8.7
u/l
26.4
25.7
0.16
95
885
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
36
1.41
0.38
1.0
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
20
163
1.28
0.37
4.0
3.5
mg/mmol
4.9
10.1
0.62
11
100
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
133
0.73
0.36
1.6
2.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
44
1.39
0.35
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
87
840
1.21
0.25
11.1
12.0
%
39.1
40.5
0.67
77
691
(36304419) Bacteria [Presence] in Urine
24
211
1.18
0.23
2.5
2.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
10
79
1.29
0.23
1.1
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
34
308
1.15
0.23
1.9
1.9
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
5
39
1.30
0.23
1.6
9.3
mmol/l
24.1
24.5
—
5
39
(3042936) Bacteria identified in Isolate by Culture
13
107
1.25
0.23
1.8
2.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
231
1.17
0.22
1.6
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
41
1.23
0.22
2.0
1.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
42
1.20
0.22
2.8
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(4281824)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(44790048)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(44790047)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(44790049)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(44806118)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
153.4
—
0
12
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
48
1.26
0.20
3.0
9.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
48
1.26
0.20
1.0
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
53
499
1.13
0.20
2.9
2.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
51
1.19
0.20
1.7
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
51
1.19
0.20
1.7
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
36
389
0.89
0.19
4.0
4.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
22
246
0.87
0.19
1.7
2.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
27
297
0.88
0.18
1.8
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
20
177
1.16
0.18
2.3
3.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
10
82
1.24
0.18
2.3
3.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
7
62
1.14
0.17
3.4
4.4
—
21.6
—
0
23
(3016879) Cocaine [Presence] in Urine
5
67
0.73
0.17
2.0
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
8
71
1.14
0.16
2.9
2.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
75
0.79
0.16
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
83
1.23
0.16
1.3
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
109
0.81
0.13
2.1
2.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
24
220
1.12
0.13
2.4
3.8
estimate
0.0
0.0
0.00
12
90
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
85
1.20
0.13
1.6
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
17
153
1.13
0.12
3.4
2.9
mg/l
31.9
66.6
0.52
11
98
(3022313) Gas panel - Capillary blood
5
43
1.17
0.10
1.6
11.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
46
1.09
0.10
1.2
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
31
293
1.08
0.09
4.5
8.2
mmol/l
1.2
1.2
0.11
31
269
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
53
1.14
0.09
1.7
1.5
—
—
—
0
0
(3019225) pH of Specimen
6
57
1.06
0.08
3.8
5.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
58
1.04
0.08
1.7
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
58
1.04
0.08
1.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
58
1.04
0.08
1.7
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
58
1.04
0.08
1.7
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
58
1.04
0.08
1.7
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
63
1.12
0.08
1.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
63
1.12
0.08
1.6
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
64
1.10
0.08
2.3
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
72
0.82
0.08
1.8
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
72
0.82
0.08
1.8
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
72
0.82
0.08
1.8
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
72
0.82
0.08
1.8
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
81
0.85
0.07
1.9
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
82
0.84
0.07
2.0
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
26
246
1.08
0.07
1.2
1.3
u/ml
6.7
1.2
—
7
64
(3019832) Treponema pallidum Ab [Presence] in Serum
18
193
0.92
0.07
1.6
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
73
716
1.06
0.06
4.0
4.2
mmol/mol
38.6
38.0
0.22
67
676
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
27
257
1.07
0.06
2.1
1.8
pmol/l
103.5
93.5
0.53
16
129
(40758558) Short blood count panel - Blood
24
228
1.07
0.05
3.0
7.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
12
110
1.10
0.05
1.8
4.7
mmol/l
0.8
0.8
0.39
12
102
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
169
0.94
0.03
1.3
1.3
u/ml
1.2
7.6
—
10
74
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
21
219
0.95
0.03
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
15
157
0.95
0.01
1.5
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
17
177
0.95
0.01
1.7
2.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
21
217
0.96
0.01
2.4
2.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
112
0.98
0.00
1.7
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
28
275
1.02
0.00
5.1
5.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
12
116
1.04
0.00
2.3
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
9
0.00
0.00
0.0
1.6
—
13.5
—
0
9
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
51
0.98
0.00
1.0
1.7
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
0.9
—
0
9
(3021788) Differential panel - Synovial fluid
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
9
0.00
0.00
0.0
1.3
—
92.4
—
0
9
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
9
99
0.90
0.00
1.2
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
2.4
—
0
6
(3051611) Lipemic interference index of Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
154.8
—
0
6
(4027681)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4024509)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
60
1.00
0.00
1.5
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
2.9
—
0
5
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
0.3
—
0
6
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
104.0
—
0
6
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
79
0.88
0.00
3.4
5.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
5.8
—
0
5
(3051651) Icteric interference index of Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
7.1
—
140.9
—
0
8
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
8.0
—
0
5
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
11.3
—
0
5
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
22.2
—
0
8
(3036782) Glucose [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
7.0
—
0
5
(4035726)
5
55
0.90
0.00
1.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint FOOD_ALLERGY and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have FOOD_ALLERGY.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: FOOD_ALLERGY – Food allergy
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data